Good day, and thank you for standing by. Welcome to Carlyle Secured Lending's Fourth Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. After this speaker presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. I would now like to hand the call over to your speaker today, Daniel Hahn. Please go ahead.

Good morning, and welcome to Carlyle Secured Lending's fourth quarter 2022 earnings call. With me on the call this morning is Linda Pace, the Chair of our Board of Directors; Aren LeeKong, our newly appointed Chief Executive Officer; and Tom Hennigan, our Chief Financial Officer. Last night, we filed our Form 10-K and issued a press release with a presentation of our results, which are available on the Investor Relations section of our website. Following our remarks today, we will hold a question-and-answer session for analysts and institutional investors. This call is being webcast, and a replay will be available on our website. Any forward-looking statements made today do not guarantee future performance, and any undue reliance should not be placed on them. These statements are based on current management expectations and involve inherent risks and uncertainties, including those identified in the Risk Factors section of our annual report on Form 10-K. These risks and uncertainties could cause actual results to differ materially from those indicated. Carlyle Secured Lending assumes no obligation to update any forward-looking statements at any time. With that, I'll turn the call over to Linda Pace.

Thank you, Dan. Good morning, everyone, and thank you all for joining us to discuss our fourth quarter and full year 2022 results. I will focus my remarks on three topics for today's call. I'll start with an overview of our fourth quarter results; second, I'll comment on the current market environment and investment activity; and finally, I'll conclude with a few thoughts on our full year 2022 performance. We generated net investment income of $0.48 per share in the fourth quarter. This was an increase of 9% from the core earnings in Q3 as the portfolio continued to benefit from higher base rates. We declared total first quarter dividends of $0.44, consisting of our new base dividend of $0.37, which we have increased for the third consecutive period plus a $0.07 supplemental. We have now increased our base dividend rate by a total of almost 16% over the last three quarters and are pleased to highlight that the $0.37 per share is now back at our IPO level. Our net asset value decreased by 1% in the fourth quarter to $16.99 per share, primarily due to the impact of widening market yields. We repurchased an additional $7.3 million of our common stock during the quarter, resulting in $0.04 of accretion to our net asset value per share. Turning now to the market. The current environment continues to be lender-friendly, allowing us to selectively deploy capital into attractive opportunities. From a macro perspective, we have still not seen a recessionary contraction in the U.S. economy, despite the increased velocity of Fed rate hikes, which occurred much more quickly than most market participants expected. We've seen a reduction in the level of uncertainty around interest rates and a reduction in inflation levels. However, fixed income and private credit continue to see volatility, driven by less liquidity and capital formation across the debt markets. This backdrop informed our investment activity, and we remain focused on deploying primarily first lien capital at attractive yields with better economics and terms. During the fourth quarter, we funded $129 million and saw total repayments and sales of $87 million. We ended 2022 with approximately $2 billion of investments at fair value. Before turning things over to Tom, I'd like to spend a few minutes on our full year 2022 results. We generated net investment income of $1.93 per share which was an increase of 26% compared to the prior year. We declared total dividends of $1.64 per share during the year, resulting in dividend coverage of 118%. We also repurchased shares that provided an additional $0.14 of accretion to NAV during the year. Our net asset value ended the year at $16.99 per share, up from $16.91 as of Q4 2021 due to strong fundamental credit performance. We're extremely pleased with these results and believe they demonstrate not only the power of our platform, but also our commitment to creating long-term shareholder value regardless of the market environment. With that, I'd like to hand the call over to our CFO, Tom Hennigan.

Thank you, Linda. Today, I'll begin with a review of our fourth quarter earnings. Then I'll provide further detail on our balance sheet positioning, and I'll conclude with a discussion of our portfolio performance. As reviewed, we had another strong quarter on the earnings front. Total investment income for the fourth quarter was $56 million, the prior quarter after taking into account the onetime impact of direct travel in Q3. This increase was driven by higher benchmark rates, a higher average investment balance and an increase in dividend income from our JVs. This increase was partially offset by lower OID accretion and fee income. Total expenses increased in the quarter from $29 million to $31 million, primarily due to higher interest expense from rising base rates on our financing facilities. The result was total net investment income for the fourth quarter of $25 million or $0.48 per share, up 9% versus $0.44 per share of core earnings in Q3. Furthermore, this is substantially above our core earnings of about $0.40 per share each quarter in the first half of 2022. Our Board of Directors declared a dividend for the first quarter of 2023 at a total level of $0.44 per share. That's comprised of our new $0.37 base dividend, up from the prior level of $0.36 plus a $0.07 supplemental, which is payable to shareholders of record at the close of business on March 31. In terms of the forward outlook for earnings, based on the combination of higher benchmark rates and attractive economics on new investments, we see continued growth in NII for the first quarter, with further upside throughout the rest of 2023 based on the latest rate curves. So we remain highly confident in our ability to comfortably meet and exceed the new $0.37 base dividend and continue paying out supplemental dividends each quarter. And as Linda mentioned, $0.37 was the base dividend at IPO and we're very pleased to be back at this level. On valuations, our total aggregate realized and unrealized net loss was $13 million for the quarter. This decrease was primarily driven by unrealized losses from widening market yields. Next, I'll touch on our financing facilities and leverage. We continue to be well positioned on the right side of our balance sheet. Statutory leverage was about 1.3 times and net financial leverage ended the quarter at 1.16 times. So while up modestly compared to the prior quarter, our leverage remains comfortably within our target range. This positioning allows us to effectively deploy capital given the attractive yields and terms available for new investments in the current market. I'll finish with a review of the portfolio and related activity. We continue to see overall credit stability and credit quality across the book. The total fair value of transactions risk rated 3 to 5, indicating some level of downgrade since we made the investment was flat this quarter. Total nonaccruals increased from 1.9% to 2.9% based on fair value due to the addition of PPT management. However, we expect further developments for that investment in the coming months, which will result in restoring to the accrual status. In addition, we anticipate any credit softness from the current macroeconomic headwinds will be buffered by further upside on the dermatology associates and direct travel positions. With that, I'll turn it back to Linda.

Thanks, Tom. We view 2022 as a year of very strong performance for the company, which we believe translated into excellent performance for our stockholders. We generated almost 18% of total return for our shareholders, which included a solid double-digit dividend yield and price appreciation in our stock price. This return represented the best total return experience for shareholders of all publicly traded BDCs with a market capitalization of over $500 million for the year. I would like to take a moment to thank the entire Carlyle team for all their hard work, and they are the reason we were able to deliver this top-tier performance. Lastly, before opening up the call for questions, I'd like to introduce our newly appointed CEO, Aren LeeKong.

Thanks, Linda. I would like to actually take this moment to publicly thank you. You've played an instrumental role in building a best-in-class credit platform over the last 20-plus years. Your contributions to the success of the platform are impressive and have been invaluable. It has been an absolute pleasure to spend my time working with you and the secured lending team as part of my role on the Board of Directors over the last few years. I've also worked with a number of the senior members of Carlyle's global credit platform in various forms over the better part of the previous two decades. Finally, I've been fortunate to spend the end of 2022 and the first couple of months of this year solidifying relationships with the deep bench of talent that exists within Carlyle direct lending and across the broader Carlyle platform. I could not be more impressed. I have every confidence in this team and in their ability to continue to deliver the results that our shareholders have come to expect. So with that said, thank you all for joining. And operator, please open the call for questions.

Our first question comes from Aaron Cyganovich of Citi.

Maybe you could just talk a little bit about the environment right now, how private equity sponsors are thinking about the market and whether or not you feel like there's going to be an increase in any kind of deal opportunities as we enter the year?

Sure. It's Linda. I'll start and let the team add their thoughts. We have a valuable perspective since we are part of the Carlyle Group. I can share that the deal environment is challenging, but there is still activity happening. A significant advantage for us and others in the private credit market is that we are witnessing a retreat from traditional lending sources. The banks and the high-yield market, along with the CLO market, have not been particularly active. As a result, private equity sponsors looking to make deals, including Carlyle, are turning to private credit because it offers them certainty in execution. They receive term sheets without excessive flex language that could allow banks to back out for reasons they may consider unusual. In this environment, they might be paying a bit more, but the terms aren't excessively strict either. The private credit markets, of which BDCs like us are a part, stand to benefit from this situation. We expect to see deal flow, enough that we can be very selective about our choices. Is there anyone else who wants to add to that?

Yes, it's Aren LeeKong. Nice to meet you, Arren. So I'd say in the first quarter, the new transactions we have, and I'm literally looking at our pipeline and closed deals as we speak, we're seeing obviously, base rates are higher. Spreads are a lot closer to 700 basis points over. That is going to continue. And Tom has already spoken about it today that is going to continue to be a positive impact to the portfolio. If you think about what is coming up for maturity over the next year or two. Those transactions are going to be replaced, which are sort of 520 basis points to 540 basis point spread transactions are going to be replaced with 675 to 700 plus spread transactions. So that is going to continue to provide positive momentum. We're seeing, as Linda alluded to, our leverage levels on new transactions are quite attractive to historical wider spreads. Because of the dearth of capital in the large liquid market and just period because the world is a little bit rockier, we are seeing tighter documents effectively. There's nothing in our pipe that doesn't have covenants. So it is a positive market for new transactions. And as you alluded to, Arren, I think we view what's in our portfolio is quite attractive. So we're also taking this opportunity to be very close to our sponsors and work with them on transactions. They will spend lots of hours knowing the companies to figure out how to keep those credits in our portfolio at more attractive rates for our shareholders. So that's sort of what we're seeing right now. And quite frankly, we do have the ability to be selective and we're taking full advantage of that.

The second question I had was on the PBT nonaccrual. I think in the prepared remarks, you had mentioned that you expect that to go back to accrual. I don't know if you can add any commentary as to what would potentially improve that situation.

Arren, it's Tom. We're being a bit cautious about what we can share since it's an ongoing situation regarding an investment. We're currently going through the usual amendment process for a deal that hasn't performed well, and we expect to have a new capital structure for that business. We anticipate a favorable outcome regarding our position in that credit possibly next quarter.

I would now like to turn the conference back to Linda Pace for closing remarks. Madam?

Thank you, and thank you, everyone, for joining today, and we look forward to speaking with you next quarter. Have a great day.

This concludes today's conference call. Thank you for participating. You may now disconnect.